Alan D. Adams

936 total citations
16 papers, 766 citations indexed

About

Alan D. Adams is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Alan D. Adams has authored 16 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Alan D. Adams's work include Cholesterol and Lipid Metabolism (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Alan D. Adams is often cited by papers focused on Cholesterol and Lipid Metabolism (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Alan D. Adams collaborates with scholars based in United States and United Kingdom. Alan D. Adams's co-authors include Carl P. Sparrow, Karen L. MacNaul, David E. Moller, Gaochao Zhou, Thomas W. Doebber, Joel P. Berger, Alex Elbrecht, John G. Menke, Michael Tanen and Richard S. Surwit and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Alan D. Adams

16 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan D. Adams United States 14 483 262 182 119 104 16 766
Henrietta Dehmlow Switzerland 15 621 1.3× 183 0.7× 121 0.7× 61 0.5× 197 1.9× 21 969
Wendelin Frick Germany 20 527 1.1× 223 0.9× 67 0.4× 173 1.5× 212 2.0× 32 932
Qiu Guo United States 16 662 1.4× 224 0.9× 114 0.6× 54 0.5× 65 0.6× 26 932
John K. Dickson United States 17 499 1.0× 232 0.9× 114 0.6× 51 0.4× 351 3.4× 34 1.1k
Curt D. Haffner United States 16 616 1.3× 243 0.9× 492 2.7× 119 1.0× 244 2.3× 22 1.2k
Marjorie J. Ray United States 6 359 0.7× 264 1.0× 187 1.0× 111 0.9× 51 0.5× 6 874
Evelyne Chaput Switzerland 12 285 0.6× 211 0.8× 138 0.8× 108 0.9× 46 0.4× 15 597
Richard Sulsky United States 12 640 1.3× 129 0.5× 78 0.4× 165 1.4× 203 2.0× 18 1.1k
Richard F. Bousley United States 17 307 0.6× 420 1.6× 71 0.4× 32 0.3× 123 1.2× 31 724
Ivan L. Pinto United Kingdom 20 507 1.0× 129 0.5× 71 0.4× 116 1.0× 489 4.7× 37 1.1k

Countries citing papers authored by Alan D. Adams

Since Specialization
Citations

This map shows the geographic impact of Alan D. Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Adams more than expected).

Fields of papers citing papers by Alan D. Adams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan D. Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Adams. The network helps show where Alan D. Adams may publish in the future.

Co-authorship network of co-authors of Alan D. Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Alan D. Adams. A scholar is included among the top collaborators of Alan D. Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan D. Adams. Alan D. Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Szewczyk, Jason W., John J. Acton, Alan D. Adams, et al.. (2010). Design of potent and selective GPR119 agonists for type II diabetes. Bioorganic & Medicinal Chemistry Letters. 21(9). 2665–2669. 21 indexed citations
2.
Soisson, S.M., Gopalakrishnan Parthasarathy, Alan D. Adams, et al.. (2008). Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation. Proceedings of the National Academy of Sciences. 105(14). 5337–5342. 79 indexed citations
3.
Szewczyk, Jason W., Jayne Chin, Lyndon J. Mitnaul, et al.. (2006). SAR studies: Designing potent and selective LXR agonists. Bioorganic & Medicinal Chemistry Letters. 16(11). 3055–3060. 13 indexed citations
4.
Lund, Erik, Laurence B. Peterson, Alan D. Adams, et al.. (2005). Different roles of liver X receptor α and β in lipid metabolism: Effects of an α-selective and a dual agonist in mice deficient in each subtype. Biochemical Pharmacology. 71(4). 453–463. 112 indexed citations
5.
Chin, Jayne, Alan D. Adams, Raul Lacson, et al.. (2003). Miniaturization of Cell-Based β -Lactamase-Dependent FRET Assays to Ultra-High Throughput Formats to Identify Agonists of Human Liver X Receptors. Assay and Drug Development Technologies. 1(6). 777–787. 25 indexed citations
6.
Adams, Alan D., Conrad Santini, A. Brian Jones, et al.. (2003). Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists. Bioorganic & Medicinal Chemistry Letters. 13(5). 931–935. 34 indexed citations
7.
Adams, Alan D., Alex Elbrecht, Karen L. MacNaul, et al.. (2003). O-Arylmandelic acids as highly selective human PPAR α/γ agonists. Bioorganic & Medicinal Chemistry Letters. 13(19). 3185–3190. 19 indexed citations
8.
Berger, Joel P., Ann Petro, Karen L. MacNaul, et al.. (2003). Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator. Molecular Endocrinology. 17(4). 662–676. 271 indexed citations
9.
Sparrow, Carl P., My‐Hanh Lam, Erik Lund, et al.. (2002). A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux. Journal of Biological Chemistry. 277(12). 10021–10027. 105 indexed citations
10.
Jones, A. Brian, John J. Acton, Alan D. Adams, et al.. (1999). Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands. Bioorganic & Medicinal Chemistry Letters. 9(14). 2115–2118. 3 indexed citations
11.
Schlessinger, R. H., Adnan M.M. Mjalli, Alan D. Adams, James P. Springer, & Karst Hoogsteen. (1992). An approach to erythronolide A seco acid via a simple tetronic acid. The Journal of Organic Chemistry. 57(11). 2992–2993. 14 indexed citations
12.
Williard, Paul G., James R. Tata, R. H. Schlessinger, Alan D. Adams, & Edwin J. Iwanowicz. (1988). Remarkably similar solution and solid-state structures for two divergently reactive lithium enolates derived from vinylogous urethanes. Journal of the American Chemical Society. 110(23). 7901–7903. 19 indexed citations
13.
Breslow, Ronald, et al.. (1987). Selective steroid chlorinations directed by attached pyridine ester templates. Journal of the American Chemical Society. 109(12). 3799–3801. 21 indexed citations
14.
Adams, Alan D., R. H. Schlessinger, James R. Tata, & John J. Venit. (1986). The structure and kinetic reactivity of a pyrrolidine-derived vinylogous urethane lithium enolate. The Journal of Organic Chemistry. 51(15). 3068–3070. 14 indexed citations
15.
Griffin, Gary W., et al.. (1984). Reactive intermediates in the photochemistry of 4-diazo-2-pyrazolin-5-ones. Canadian Journal of Chemistry. 62(11). 2456–2463. 3 indexed citations
16.
Eǧe, Seyhan N., et al.. (1983). Oxopyrazoline-spiro-oxirans. A new class of reactive heterocycles. Journal of the Chemical Society Perkin Transactions 1. 325–331. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henrietta Dehmlow Breakdown of academic impact, for papers by Wendelin Frick Breakdown of academic impact, for papers by Qiu Guo Breakdown of academic impact, for papers by John K. Dickson Breakdown of academic impact, for papers by Curt D. Haffner Breakdown of academic impact, for papers by Marjorie J. Ray Breakdown of academic impact, for papers by Evelyne Chaput Breakdown of academic impact, for papers by Richard Sulsky Breakdown of academic impact, for papers by Richard F. Bousley Breakdown of academic impact, for papers by Ivan L. Pinto
Rankless by CCL
2026